Skip to main content
Infection and Drug Resistance logoLink to Infection and Drug Resistance
. 2022 Sep 20;15:5543–5544. doi: 10.2147/IDR.S389192

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness [Corrigendum]

PMCID: PMC9508893  PMID: 36164336

Reynolds MW, Xie Y, Knuth KB, et al. Infect Drug Resist. 2022;1:5167–5182.

Page 5172, Figure 2, the text “7,352 completed vaccine regimen” should read “7,532 completed vaccine regimen” and “1,014 never reported infection” should read “1,414 never reported infection”. The correct Figure 2 is as follows.

Figure 2.

Figure 2

 Flowchart of study sample and participant counts with COVID-19 infection.

Page 5172, COVID-19 Infected Study Participants section, 2nd line, the text “(31.8% and 20.3%, were college-educated versus 40.5% among fully vaccinated)” should read “(31.8% and 20.3%, were above-college-educated versus 40.5% among fully vaccinated)”.

Page 5172, COVID-19 Symptoms and Impact Among Vaccinated vs Unvaccinated section, 2nd paragraph, line 6, the text “1.6% among the 198 infected after partial vaccination, and 2.0% among the 3018 infected while unvaccinated” should read “2.0% among the 198 infected after partial vaccination, and 1.6% among the 3018 infected while unvaccinated”.

The authors apologize for any confusion this may have caused.


Articles from Infection and Drug Resistance are provided here courtesy of Dove Press

RESOURCES